High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Loiodice I, Alves A, Rabut G et al. The entire Nup107–160 complex, including three new members, is targeted as one entity to kinetochores in mitosis. Mol. Biol. Cell 15(7), 3333–3344 (2004). •• Key literature showing the functional role of Nup43 and the Nup107–160 complex.
  Medline CASGoogle Scholar
• 2 Simon DN, Rout MP. Cancer and the nuclear pore complex. Adv. Exp. Med. Biol. 773, 285–307 (2014).
  Medline CASGoogle Scholar
• 3 Karacosta LG, Kuroski LA, Hofmann WA et al. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells. Prostate 76(3), 294–306 (2016).
  Medline CASGoogle Scholar
• 4 Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nunez-Villar MJ, Pollan M, Schneider J. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int. J. Cancer 109(5), 717–720 (2004).
  Medline CASGoogle Scholar
• 5 Zhao ZR, Zhang ZY, He XQ et al. Nup88 mRNA overexpression in colorectal cancers and relationship with p53. Cancer Biomark. 8(2), 73–80 (2010).
  Medline CASGoogle Scholar
• 6 Hollink IH, Van Den Heuvel-Eibrink MM, Arentsen-Peters ST et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 118(13), 3645–3656 (2011).
  Medline CASGoogle Scholar
• 7 Salsi V, Ferrari S, Gorello P et al. NUP98 fusion oncoproteins promote aneuploidy by attenuating the mitotic spindle checkpoint. Cancer Res. 74(4), 1079–1090 (2014).
  Medline CASGoogle Scholar
• 8 Kim SY, Kang HT, Choi HR, Park SC. Reduction of Nup107 attenuates the growth factor signaling in the senescent cells. Biochem. Biophys. Res. Commun. 401(1), 131–136 (2010). • Shows the possible regulative effect of the Nup107–160 complex in cancer-related growth factor signaling.
  Medline CASGoogle Scholar
• 9 Alanee S, Delfino K, Wilber A, Robinson K, Brard L, Semaan A. Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer. Pharmacogenet. Genomics 27(7), 264–269 (2017). • Suggests that SNP in Nup107 might influence drug sensitivity in cancer.
  Medline CASGoogle Scholar
• 10 Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumors. Nature 490(7418), 61–70 (2012).
  MedlineGoogle Scholar
• 11 Ma CX, Ellis MJ. The Cancer Genome Atlas: clinical applications for breast cancer. Oncology (Williston Park) 27(12), 1263–1269, 1274–1279 (2013).
  MedlineGoogle Scholar
• 12 Reynisdottir I, Arason A, Einarsdottir BO et al. High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer. Cancer Med. 2(4), 437–446 (2013).
  Medline CASGoogle Scholar
• 13 Kwon MJ, Han J, Seo JH et al. CD24 overexpression is associated with poor prognosis in luminal A and triple-negative breast cancer. PLoS ONE 10(10), e0139112 (2015).
  MedlineGoogle Scholar
• 14 Uhlen M, Fagerberg L, Hallstrom BM et al. Proteomics. Tissue-based map of the human proteome. Science 347(6220), 1260419 (2015).
  MedlineGoogle Scholar
• 15 Uhlen M, Oksvold P, Fagerberg L et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28(12), 1248–1250 (2010).
  Medline CASGoogle Scholar
• 16 Gyorffy B, Lanczky A, Eklund AC et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res. Treat. 123(3), 725–731 (2010).
  MedlineGoogle Scholar
• 17 Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100(14), 8418–8423 (2003).
  Medline CASGoogle Scholar
• 18 Powe DG, Dhondalay GK, Lemetre C et al. DACH1: its role as a classifier of long-term good prognosis in luminal breast cancer. PLoS ONE 9(1), e84428 (2014).
  MedlineGoogle Scholar
• 19 Soysal SD, Muenst S, Barbie T et al. EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like and HER2 intrinsic subtypes of breast cancer. Br. J. Cancer 108(7), 1480–1487 (2013).
  Medline CASGoogle Scholar
• 20 Naylor RM, Jeganathan KB, Cao X, Van Deursen JM. Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J. Clin. Invest. 126(2), 543–559 (2016).
  MedlineGoogle Scholar
• 21 Funasaka T, Balan V, Raz A, Wong RW. Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking. Biochem. Biophys. Res. Commun. 434(1), 155–161 (2013).
  Medline CASGoogle Scholar
• 22 Jagot-Lacoussiere L, Faye A, Bruzzoni-Giovanelli H, Villoutreix BO, Rain JC, Poyet JL. DNA damage-induced nuclear translocation of Apaf-1 is mediated by nucleoporin Nup107. Cell Cycle 14(8), 1242–1251 (2015).
  Medline CASGoogle Scholar
• 23 Matchett KB, McFarlane S, Hamilton SE et al. Ran GTPase in nuclear envelope formation and cancer metastasis. Adv. Exp. Med. Biol. 773, 323–351 (2014).
  Medline CASGoogle Scholar
• 24 The Human Protein Atlas. NUP43. www.proteinatlas.org/ENSG00000120253-NUP43/tissue/breast#img.
  Google Scholar